Zalewska, M.; Fus, W.; Konka, A.; Wystyrk, K.; Bochenek, A.; Botor, H.; Fronczek, M.; Zembala-John, J.; Adamek, B.
An Immune Response to Heterologous ChAdOx1/BNT162b2 Vaccination against COVID-19: Evaluation of the anti-RBD Specific IgG Antibodies Titers and Interferon Gamma Release Assay (IGRA) Test Results. Vaccines 2022, 10, 1546.
https://doi.org/10.3390/vaccines10091546
AMA Style
Zalewska M, Fus W, Konka A, Wystyrk K, Bochenek A, Botor H, Fronczek M, Zembala-John J, Adamek B.
An Immune Response to Heterologous ChAdOx1/BNT162b2 Vaccination against COVID-19: Evaluation of the anti-RBD Specific IgG Antibodies Titers and Interferon Gamma Release Assay (IGRA) Test Results. Vaccines. 2022; 10(9):1546.
https://doi.org/10.3390/vaccines10091546
Chicago/Turabian Style
Zalewska, Marzena, Wiktoria Fus, Adam Konka, Karolina Wystyrk, Aneta Bochenek, Hanna Botor, Martyna Fronczek, Joanna Zembala-John, and Brygida Adamek.
2022. "An Immune Response to Heterologous ChAdOx1/BNT162b2 Vaccination against COVID-19: Evaluation of the anti-RBD Specific IgG Antibodies Titers and Interferon Gamma Release Assay (IGRA) Test Results" Vaccines 10, no. 9: 1546.
https://doi.org/10.3390/vaccines10091546
APA Style
Zalewska, M., Fus, W., Konka, A., Wystyrk, K., Bochenek, A., Botor, H., Fronczek, M., Zembala-John, J., & Adamek, B.
(2022). An Immune Response to Heterologous ChAdOx1/BNT162b2 Vaccination against COVID-19: Evaluation of the anti-RBD Specific IgG Antibodies Titers and Interferon Gamma Release Assay (IGRA) Test Results. Vaccines, 10(9), 1546.
https://doi.org/10.3390/vaccines10091546
